CCL11 and neoplasm: IL‐33, a tumour‐derived alarmin, in solid tumour induces eosinophil migration and promotes CCL11‐mediated eosinophil infiltration and degranulation, which in turn leads to tumour cell cytotoxicity and reduced tumour growth.